300896 爱美客
已收盘 08-31 15:00:00
资讯
新帖
简况
爱美客半年报：竞争加剧两大产品线双双下滑 高商誉与仲裁风险待化解
新浪证券 · 08-27
爱美客半年报：竞争加剧两大产品线双双下滑 高商誉与仲裁风险待化解
国金证券：给予爱美客买入评级
证券之星 · 08-24
国金证券：给予爱美客买入评级
爱美客：截至2026年6月30日“AestheFill”已获39个国家和地区注册批准
证券之星 · 08-24
爱美客：截至2026年6月30日“AestheFill”已获39个国家和地区注册批准
股价较高点跌超八成，“医美茅”爱美客再遇“业绩坎”
雷达财经 · 08-23
股价较高点跌超八成，“医美茅”爱美客再遇“业绩坎”
爱美客：橙毒目前处于上市初期
证券之星 · 08-21
爱美客：橙毒目前处于上市初期
爱美客：米诺地尔相关产品正按照既定市场策略稳步推进销售工作
证券之星 · 08-21
爱美客：米诺地尔相关产品正按照既定市场策略稳步推进销售工作
爱美客：关于未来是否在半年报披露境外营收的详细情况
证券之星 · 08-21
爱美客：关于未来是否在半年报披露境外营收的详细情况
爱美客：研发费用下降主要系在研产品所处研发阶段发生变化
证券之星 · 08-21
爱美客：研发费用下降主要系在研产品所处研发阶段发生变化
爱美客：公司肉毒毒素产品解索橙Hutox于2026年8月3日正式上市销售
证券之星 · 08-21
爱美客：公司肉毒毒素产品解索橙Hutox于2026年8月3日正式上市销售
爱美客：截至2026年8月20日，公司股东人数为57,405户
证券之星 · 08-21
爱美客：截至2026年8月20日，公司股东人数为57,405户
爱美客：控股子公司韩国REGEN与达透公司的仲裁案件尚在审理中
证券之星 · 08-21
爱美客：控股子公司韩国REGEN与达透公司的仲裁案件尚在审理中
爱美客(300896)8月10日股东户数5.92万户，较上期减少3.7%
证券之星 · 08-21
爱美客(300896)8月10日股东户数5.92万户，较上期减少3.7%
股市必读：爱美客新发布《2026年半年度报告摘要》
证券之星 · 08-21
股市必读：爱美客新发布《2026年半年度报告摘要》
爱美客最新公告：拟推2026年员工持股计划
证券之星 · 08-20
爱美客最新公告：拟推2026年员工持股计划
爱美客：该投资为石毅峰先生的个人投资
证券之星 · 08-17
爱美客：该投资为石毅峰先生的个人投资
爱美客：控股子公司韩国REGEN与达透公司的仲裁案件尚在审理中
证券之星 · 08-13
爱美客：控股子公司韩国REGEN与达透公司的仲裁案件尚在审理中
爱美客：关于公司组织架构您可以查阅公司于2026年3月20日在巨潮资讯网披露的《2025年可持续发展报告》
证券之星 · 08-13
爱美客：关于公司组织架构您可以查阅公司于2026年3月20日在巨潮资讯网披露的《2025年可持续发展报告》
爱美客：公司出海业务按照国际化战略布局正常推进
证券之星 · 08-12
爱美客：公司出海业务按照国际化战略布局正常推进
股市必读：爱美客(300896)股东户数5.92万户，较上期减少3.7%
证券之星 · 08-12
股市必读：爱美客(300896)股东户数5.92万户，较上期减少3.7%
爱美客：司美格鲁肽注射液项目按计划正常推进
证券之星 · 08-11
爱美客：司美格鲁肽注射液项目按计划正常推进
加载更多
公司概况
公司名称：
爱美客技术发展股份有限公司
所属行业：
专用设备制造业
上市日期：
2020-09-28
主营业务：
爱美客技术发展股份有限公司的主营业务是生物医用材料及生物医药的研发、生产和销售。公司的主要产品是注射类皮肤填充剂、注射用A型肉毒毒素、医美设备。公司作为主要完成单位共同攻关的“牙/颌修复新材料研发及其临床技术体系构建”项目，于2026年7月荣获“2025年度国家科学技术进步奖二等奖”。
发行价格：
118.27
{"stockData":{"symbol":"300896","market":"SZ","secType":"STK","nameCN":"爱美客","latestPrice":92.81,"timestamp":1788159813000,"preClose":94.09,"halted":0,"volume":2013064,"delay":0,"changeRate":-0.0136,"floatShares":221000000,"shares":303000000,"eps":3.6185,"marketStatus":"已收盘","change":-1.28,"latestTime":"08-31 15:00:00","open":94,"high":94.5,"low":91.79,"amount":186000000,"amplitude":0.0288,"askPrice":92.82,"askSize":1,"bidPrice":92.81,"bidSize":14,"shortable":0,"etf":0,"ttmEps":3.6185,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1788226200000},"marketStatusCode":5,"adr":0,"adjPreClose":94.09,"symbolType":"stock","openAndCloseTimeList":[[1788139800000,1788147000000],[1788152400000,1788159600000]],"highLimit":103.5,"lowLimit":84.68,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":302592061,"isCdr":false,"pbRate":3.6,"roa":"--","peRate":25.648749,"roe":"7.62%","epsLYR":4.28,"committee":0.705263,"marketValue":28084000000,"turnoverRate":0.0091,"status":1,"floatMarketCap":20512000000},"requestUrl":"/m/hq/s/300896","defaultTab":"news","newsList":[{"id":"2662877193","title":"爱美客半年报：竞争加剧两大产品线双双下滑 高商誉与仲裁风险待化解","url":"https://stock-news.laohu8.com/highlight/detail?id=2662877193","media":"新浪证券","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662877193?lang=zh_cn&edition=full","pubTime":"2026-08-27 16:15","pubTimestamp":1787818500,"startTime":"0","endTime":"0","summary":"近日，爱美客披露2026年半年度报告。继2025年出现上市以来首次年度营收净利双降后，爱美客再次交出业绩下滑的成绩单。赛道竞争白热化两大产品线双双下滑分产品来看，曾经支撑爱美客业绩高速增长的两大核心产品线全面失速。13亿元的商誉规模，相当于爱美客2026年上半年净利润的两倍有余，占公司净资产比例超过16%。截至2026年半年报披露日，该仲裁案件仍在审理过程中，最终结果存在重大不确定性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/observe/2026-08-27/doc-iniptxkt5351864.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["300896","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661274649","title":"国金证券：给予爱美客买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2661274649","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661274649?lang=zh_cn&edition=full","pubTime":"2026-08-24 21:55","pubTimestamp":1787579740,"startTime":"0","endTime":"0","summary":"国金证券股份有限公司甘坛焕近期对爱美客进行研究并发布了研究报告《业绩短期承压，新品放量构筑新增长》，给予爱美客买入评级。最新盈利预测明细如下：该股最近90天内共有7家机构给出评级，买入评级7家；过去90天内机构目标均价为155.04。本文数据来源于国金证券股份有限公司，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082400036427.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300896"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661273952","title":"爱美客：截至2026年6月30日“AestheFill”已获39个国家和地区注册批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2661273952","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661273952?lang=zh_cn&edition=full","pubTime":"2026-08-24 17:42","pubTimestamp":1787564550,"startTime":"0","endTime":"0","summary":"证券之星消息，爱美客08月24日在投资者关系平台上答复投资者关心的问题。爱美客回复：尊敬的投资者您好，公司根据会计准则规定对固定资产进行折旧并按信息披露的要求，在定期报告中披露公司合并层面固定资产本期计提折旧总金额，REGEN公司工厂折旧金额未单独列示；关于“AestheFill”的市场拓展，公司除了巩固现有销售渠道与客户群体的同时，积极布局海外市场，截至2026年6月30日“AestheFill”已获得了39个国家和地区的注册批准。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082400024955.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300896","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661217741","title":"股价较高点跌超八成，“医美茅”爱美客再遇“业绩坎”","url":"https://stock-news.laohu8.com/highlight/detail?id=2661217741","media":"雷达财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661217741?lang=zh_cn&edition=full","pubTime":"2026-08-23 13:47","pubTimestamp":1787464076,"startTime":"0","endTime":"0","summary":"雷达财经出品 文|周慧 编|孟帅主力产品承压，“医美茅”爱美客再度交出一份营收、净利双降的业绩答卷。截至8月21日收盘，爱美客报92.36元/股，股价较历史高点跌超八成，最新市值为279.47亿元。上半年营收净利双降，销售费用激增8月20日，被誉为“医美茅”的爱美客，交出了一份营收、净利双降的半年度业绩答卷。营收、净利双双下滑之际，爱美客的销售费用却在飙升。截至上半年末，爱美客的总资产为91.79亿元，负债合计6.83亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://tech.ifeng.com/c/8vp4pA3BiFs","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"ifeng_tech","symbols":["300896","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661267690","title":"爱美客：橙毒目前处于上市初期","url":"https://stock-news.laohu8.com/highlight/detail?id=2661267690","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661267690?lang=zh_cn&edition=full","pubTime":"2026-08-21 19:12","pubTimestamp":1787310727,"startTime":"0","endTime":"0","summary":"证券之星消息，爱美客08月21日在投资者关系平台上答复投资者关心的问题。橙毒目前处于上市初期，公司正在有序开展合规医美机构准入、医生学术培训等渠道建设工作。肉毒素产品盈利受市场因素影响，相关经营情况将体现在公司后续定期报告中。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082100038173.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300896","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661262038","title":"爱美客：米诺地尔相关产品正按照既定市场策略稳步推进销售工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2661262038","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661262038?lang=zh_cn&edition=full","pubTime":"2026-08-21 18:54","pubTimestamp":1787309647,"startTime":"0","endTime":"0","summary":"证券之星消息，爱美客(300896)08月21日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好，米诺地尔搽剂2%/5%在2026上半年是否已经实现大规模铺货？请问公司对该产品2026全年营收的内部目标大概是多少？爱美客回复：尊敬的投资者您好，公司米诺地尔相关产品正按照既定市场策略稳步推进销售工作，相关业绩情况请您关注公司定期报告。感谢您的关注。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082100035485.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300896","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661902262","title":"爱美客：关于未来是否在半年报披露境外营收的详细情况","url":"https://stock-news.laohu8.com/highlight/detail?id=2661902262","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661902262?lang=zh_cn&edition=full","pubTime":"2026-08-21 18:51","pubTimestamp":1787309475,"startTime":"0","endTime":"0","summary":"证券之星消息，爱美客08月21日在投资者关系平台上答复投资者关心的问题。关于未来是否在半年报披露境外营收的详细情况，公司将根据监管政策、经营实际及投资者需求综合评估。具体以公司披露的定期报告为准。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082100035404.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300896"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661262188","title":"爱美客：研发费用下降主要系在研产品所处研发阶段发生变化","url":"https://stock-news.laohu8.com/highlight/detail?id=2661262188","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661262188?lang=zh_cn&edition=full","pubTime":"2026-08-21 18:51","pubTimestamp":1787309475,"startTime":"0","endTime":"0","summary":"证券之星消息，爱美客(300896)08月21日在投资者关系平台上答复投资者关心的问题。投资者提问：公司今年上半年营销费用同比大增63%，但研发费用同比下滑10%，与公司标榜的注重研发、技术实力强大有所不符，请问研发费用减少是暂时性的还是公司战略调整？谢谢！爱美客回复：尊敬的投资者您好，公司研发费用下降主要系在研产品所处研发阶段发生变化，阶段性投入需求减少所致，属于正常的研发周期波动，并非公司缩减研发投入或研发能力减弱。感谢您的关注。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082100035403.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300896","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661262927","title":"爱美客：公司肉毒毒素产品解索橙Hutox于2026年8月3日正式上市销售","url":"https://stock-news.laohu8.com/highlight/detail?id=2661262927","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661262927?lang=zh_cn&edition=full","pubTime":"2026-08-21 18:51","pubTimestamp":1787309466,"startTime":"0","endTime":"0","summary":"证券之星消息，爱美客08月21日在投资者关系平台上答复投资者关心的问题。预期什么时候会有结果，这问题董秘比较专业，还请详细解答。国际市场主要哪些国家。2026年能贡献多少营收？本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082100035400.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300896","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661262578","title":"爱美客：截至2026年8月20日，公司股东人数为57,405户","url":"https://stock-news.laohu8.com/highlight/detail?id=2661262578","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661262578?lang=zh_cn&edition=full","pubTime":"2026-08-21 18:48","pubTimestamp":1787309288,"startTime":"0","endTime":"0","summary":"证券之星消息，爱美客(300896)08月21日在投资者关系平台上答复投资者关心的问题。投资者提问：请问，截至2026年八月 20日公司的股东总数是多少？谢谢爱美客回复：尊敬的投资者您好，截至2026年8月20日，公司股东人数为57,405户。感谢您对公司的关注。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082100035314.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300896","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661262546","title":"爱美客：控股子公司韩国REGEN与达透公司的仲裁案件尚在审理中","url":"https://stock-news.laohu8.com/highlight/detail?id=2661262546","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661262546?lang=zh_cn&edition=full","pubTime":"2026-08-21 18:48","pubTimestamp":1787309284,"startTime":"0","endTime":"0","summary":"证券之星消息，爱美客(300896)08月21日在投资者关系平台上答复投资者关心的问题。投资者提问：根据公开信息，江苏吴中已被申请破产重整，请问该事项是否会对公司关于臻爱塑菲系列产品经销权的官司带来正面影响，谢谢！爱美客回复：尊敬的投资者您好，公司控股子公司韩国REGEN与达透公司的仲裁案件，目前尚在审理中，公司会根据案件进展情况及时履行信息披露义务。感谢您的关注。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082100035309.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300896","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661727269","title":"爱美客(300896)8月10日股东户数5.92万户，较上期减少3.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661727269","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661727269?lang=zh_cn&edition=full","pubTime":"2026-08-21 17:48","pubTimestamp":1787305702,"startTime":"0","endTime":"0","summary":"证券之星消息，近日爱美客披露，截至2026年8月10日公司股东户数为5.92万户，较7月31日减少2274.0户，减幅为3.7%。在医疗美容行业个股中，爱美客股东户数高于行业平均水平，截至8月10日，医疗美容行业平均股东户数为3.31万户。从股价来看，2026年7月31日至2026年8月10日，爱美客区间跌幅为3.14%，在此期间股东户数减少2274.0户，减幅为3.7%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082100032925.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300896","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661236024","title":"股市必读：爱美客新发布《2026年半年度报告摘要》","url":"https://stock-news.laohu8.com/highlight/detail?id=2661236024","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661236024?lang=zh_cn&edition=full","pubTime":"2026-08-21 00:54","pubTimestamp":1787244851,"startTime":"0","endTime":"0","summary":"公司公告汇总：公司将于2026年9月9日召开2026年第一次临时股东大会，审议《2026年员工持股计划（草案）》及其摘要、管理办法，并提请授权董事会办理相关事宜。爱美客技术发展股份有限公司2026年员工持股计划管理办法公司制定2026年员工持股计划管理办法，明确持有人为公司董事、高级管理人员、中层管理人员及核心技术（业务）人员，总","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082100000871.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300896","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660028402","title":"爱美客最新公告：拟推2026年员工持股计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2660028402","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660028402?lang=zh_cn&edition=full","pubTime":"2026-08-20 20:40","pubTimestamp":1787229613,"startTime":"0","endTime":"0","summary":"爱美客(300896.SZ)公告称，公司发布2026年员工持股计划(草案)，拟受让公司回购专用账户中A股普通股股票，股份总数不超过116.5874万股，约占公司股本总额的0.39%。参加对象为公司董事、高级管理人员、中层管理人员及核心技术(业务)人员，总人数不超过189人，受让价格为49.29元/股。本计划存续期为36个月，分两批解锁，解锁比例各为50%。业绩考核年度为2026-2027年，2026年营收目标不低于25.75亿元，2026-2027年累计营收目标不低于54.09亿元。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082000041492.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300896"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660482854","title":"爱美客：该投资为石毅峰先生的个人投资","url":"https://stock-news.laohu8.com/highlight/detail?id=2660482854","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660482854?lang=zh_cn&edition=full","pubTime":"2026-08-17 19:15","pubTimestamp":1786965309,"startTime":"0","endTime":"0","summary":"证券之星消息，爱美客08月17日在投资者关系平台上答复投资者关心的问题。成都锐翼生物的肉毒毒素目前处于早期临床试验申请阶段，短期内不会与公司经营的产品形成竞争，对公司不构成实质利益冲突。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081700028515.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300896","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659132571","title":"爱美客：控股子公司韩国REGEN与达透公司的仲裁案件尚在审理中","url":"https://stock-news.laohu8.com/highlight/detail?id=2659132571","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659132571?lang=zh_cn&edition=full","pubTime":"2026-08-13 16:21","pubTimestamp":1786609267,"startTime":"0","endTime":"0","summary":"证券之星消息，爱美客(300896)08月13日在投资者关系平台上答复投资者关心的问题。投资者提问：公司跟江苏吴中的公司多久能结束？目前对公司有啥不利的影响吗？爱美客回复：尊敬的投资者您好，公司控股子公司韩国REGEN与达透公司的仲裁案件，目前尚在审理中，公司会根据案件进展情况及时履行信息披露义务。感谢您的关注。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081300025577.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300896","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659134510","title":"爱美客：关于公司组织架构您可以查阅公司于2026年3月20日在巨潮资讯网披露的《2025年可持续发展报告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2659134510","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659134510?lang=zh_cn&edition=full","pubTime":"2026-08-13 15:39","pubTimestamp":1786606752,"startTime":"0","endTime":"0","summary":"证券之星消息，爱美客(300896)08月13日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司目前在业务和职能上是怎么样的组织和管理架构，是否有调整组织架构的计划，目前公司定期报告中关于公司组织架构相关事项提及较少，请问关于公司的组织架构有哪些更详细的资料和信息可供参考，谢谢！爱美客回复：尊敬的投资者您好，关于公司组织架构您可以查阅公司于2026年3月20日在巨潮资讯网披露的《2025年可持续发展报告》，感谢您的关注。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：沈彬","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081300020737.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300896","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658244669","title":"爱美客：公司出海业务按照国际化战略布局正常推进","url":"https://stock-news.laohu8.com/highlight/detail?id=2658244669","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658244669?lang=zh_cn&edition=full","pubTime":"2026-08-12 15:12","pubTimestamp":1786518738,"startTime":"0","endTime":"0","summary":"证券之星消息，爱美客(300896)08月12日在投资者关系平台上答复投资者关心的问题。投资者提问：请问出海业务今年会有实质性的提升吗？请董秘大白话告诉我们爱美客回复：尊敬的投资者您好，公司出海业务按照国际化战略布局正常推进，相关情况您可关注公司定期报告，感谢您的关注。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081200020395.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300896","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658912061","title":"股市必读：爱美客(300896)股东户数5.92万户，较上期减少3.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658912061","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658912061?lang=zh_cn&edition=full","pubTime":"2026-08-12 01:42","pubTimestamp":1786470133,"startTime":"0","endTime":"0","summary":"截至2026年8月11日收盘，爱美客报收于103.63元，下跌1.85%，换手率2.31%，成交量4.72万手，成交额4.93亿元。股本股东变化：截至2026年8月10日，爱美客股东户数为5.92万户，较7月31日减少3.7%。股本股东变化股东户数变动截至2026年8月10日，公司股东户数为5.92万户，较7月31日减少2274.0户，减幅为3.7%；户均持股数量由4921.0股增至5110.0股，户均持股市值为53.95万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081200001864.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300896","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658960293","title":"爱美客：司美格鲁肽注射液项目按计划正常推进","url":"https://stock-news.laohu8.com/highlight/detail?id=2658960293","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658960293?lang=zh_cn&edition=full","pubTime":"2026-08-11 15:30","pubTimestamp":1786433436,"startTime":"0","endTime":"0","summary":"证券之星消息，爱美客(300896)08月11日在投资者关系平台上答复投资者关心的问题。投资者提问：请问ai有没有可能提升公司的减肥药进度加快？爱美客回复：尊敬的投资者您好，截至目前，公司“司美格鲁肽注射液”项目按计划正常推进。感谢您的关注。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081100019344.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300896"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1788197979732,"stockEarnings":[{"period":"1week","weight":0.0154},{"period":"1month","weight":-0.1485},{"period":"3month","weight":-0.0839},{"period":"6month","weight":-0.3284},{"period":"1year","weight":-0.5151},{"period":"ytd","weight":-0.3406}],"compareEarnings":[{"period":"1week","weight":0.0269},{"period":"1month","weight":0.0402},{"period":"3month","weight":-0.0218},{"period":"6month","weight":-0.0236},{"period":"1year","weight":0.0333},{"period":"ytd","weight":0.0044}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"爱美客技术发展股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"57405人(较上一季度减少3.07%)","perCapita":"3850股","listingDate":"2020-09-28","address":"北京市昌平区科技园区白浮泉路10号北控科技大厦4层416B室","registeredCapital":"30259万元","survey":" 爱美客技术发展股份有限公司的主营业务是生物医用材料及生物医药的研发、生产和销售。公司的主要产品是注射类皮肤填充剂、注射用A型肉毒毒素、医美设备。公司作为主要完成单位共同攻关的“牙/颌修复新材料研发及其临床技术体系构建”项目，于2026年7月荣获“2025年度国家科学技术进步奖二等奖”。","listedPrice":118.27},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"爱美客(300896)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供爱美客(300896)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"爱美客,300896,爱美客股票,爱美客股票老虎,爱美客股票老虎国际,爱美客行情,爱美客股票行情,爱美客股价,爱美客股市,爱美客股票价格,爱美客股票交易,爱美客股票购买,爱美客股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"爱美客(300896)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供爱美客(300896)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}